XML 17 R3.htm IDEA: XBRL DOCUMENT v3.21.1
Unaudited Consolidated Balance Sheets (Parentheticals) - USD ($)
$ in Thousands
Mar. 31, 2021
Dec. 31, 2020
Fixed maturities available for sale, at amortized cost $ 18,447,720 $ 18,143,305
Allowance for credit losses on investments 3,830 2,397
Short-term investments available for sale, at amortized cost 1,269,312 1,924,292
Collateral received under securities lending, at amortized cost 143,886 301,089
Other investments measured at fair value 3,935,354 3,824,796
Securities pledged under securities lending, at amortized cost 142,129 294,493
Allowance for credit losses on premiums receivable 36,111 37,781
Allowance for credit losses on reinsurance recoverable 10,872 11,636
Allowance for credit losses on contractholder receivable $ 5,853 $ 8,638
Common shares, par value per share $ 0.0011 $ 0.0011
Common shares issued (shares) 581,226,408 579,000,841
Common shares held in treasury (shares) 177,913,031 172,280,199
Fixed maturities    
Allowance for credit losses on investments $ 3,830 $ 2,397
Short-term investments    
Allowance for credit losses on investments 0 [1] 0
Short-term investments available for sale, at amortized cost $ 1,269,312 $ 1,924,292
[1] Effective January 1, 2020, the Company adopted ASU 2016-13 and as a result any credit impairment losses on the Company’s available-for-sale investments are recorded as an allowance, subject to reversal.